RxDoctor Payments Data

Melanie Gardner, MD

Family Medicine · Blountsville, ALNPI 1679542096

Payments from drug & device makers

$1,115in general payments, 2019–2025

Across 61 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$210
  • AstraZeneca$145
  • Exact Sciences$138
  • GSK$120
  • Novo Nordisk$112
  • AbbVie$99
  • plus $292 from 10 others

What the payments were for

  • Food & beverage$1,03092%
  • Education$858%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,115 in reported general payments places this provider in the 55th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$17,719
Medicare patients
146
Services billed
647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide93$118,186
Trelegy ElliptaFluticasone/Umeclidin/Vilanter90$94,957
JardianceEmpagliflozin100$81,247
LinzessLinaclotide64$63,947
TrulicityDulaglutide59$61,022
EliquisApixaban61$57,158
OzempicSemaglutide50$50,084
JanuviaSitagliptin Phosphate51$37,156
RybelsusSemaglutide31$35,038
MyrbetriqMirabegron47$32,066
FarxigaDapagliflozin Propanediol37$29,190
XareltoRivaroxaban27$21,135
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$16,696
Tresiba Flextouch U-200Insulin Degludec14$13,170
Breo ElliptaFluticasone/Vilanterol14$6,440

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$210$179,208152 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$120$105,826127 claims
Novo NordiskOzempic, Rybelsus$112$85,12281 claims
AbbVieLinzess$99$63,94764 claims
PfizerEliquis$19$57,15861 claims
AstraZenecaFarxiga, Breztri Aerosphere$145$45,88661 claims
Astellas Pharma US IncMyrbetriq$85$32,06647 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Blountsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →